+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ultrasound-Guided Breast Biopsy Market - Global Forecast 2026-2032- Product Image
Ultrasound-Guided Breast Biopsy Market - Global Forecast 2026-2032- Product Image
Sale

Ultrasound-Guided Breast Biopsy Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120913
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Ultrasound-Guided Breast Biopsy Market is projected to reach USD 199.65 Million in 2026. It is expected to continue growing at a CAGR of 10.22%, reaching USD 358.34 Million by 2032.

Ultrasound-Guided Breast Biopsy: Executive Overview

Ultrasound-guided breast biopsy uses real-time imaging to direct tissue sampling from a breast abnormality. It is particularly relevant when a lesion is visible on ultrasound, including masses that may not be palpable. The approach supports targeted sampling without ionizing radiation and can be performed in an outpatient setting, subject to clinical assessment, imaging findings, and local protocols.

Clinical Practice Is Shifting Toward More Targeted, Patient-Centered Sampling

The landscape is being shaped by wider adoption of image-guided diagnosis, greater emphasis on minimizing unnecessary surgery, and stronger integration between screening, diagnostic imaging, pathology, and follow-up care. Improvements in ultrasound resolution, needle guidance, tissue-handling protocols, and multidisciplinary review are helping clinicians pursue representative samples while managing discomfort, bleeding risk, and repeat-procedure needs. Standardization of reporting and biopsy indications remains important because practice varies with lesion characteristics, patient factors, and available expertise.

Artificial Intelligence Is Enhancing Detection, Triage, and Workflow Support

Artificial intelligence is increasingly being evaluated and deployed as a support tool for breast ultrasound interpretation, lesion characterization, examination quality assessment, and workflow prioritization. Its cumulative impact may include more consistent identification of suspicious findings, improved correlation between imaging and pathology, and better documentation of procedural information. However, AI does not replace radiologist judgment or histopathology. Clinical validation, representative training data, transparent performance assessment, cybersecurity, and human oversight are essential before integrating these tools into biopsy decisions.

Regional Insights: Uneven Access Shapes Adoption and Outcomes

In North America, established breast-imaging services and coordinated diagnostic pathways support use of image-guided biopsy, while reimbursement, staffing, and access disparities remain practical considerations. Europe combines mature screening systems with national differences in referral, accreditation, and equipment availability. Asia-Pacific spans advanced urban imaging networks and areas where specialist access is limited, creating a strong need for scalable training and mobile or decentralized services. Latin America is influenced by variation in screening access, public-sector capacity, and referral delays. The Middle East is seeing continued development of specialist healthcare infrastructure, with implementation differing by country and institution. Africa faces pronounced disparities in diagnostic equipment, pathology capacity, and trained personnel, making integrated referral and capacity-building programs especially important.

Group Insights: Policy Blocs Reflect Different Health-System Priorities

ASEAN members show varied levels of imaging infrastructure, specialist availability, and public financing, so regional collaboration and workforce development can help reduce service gaps. BRICS countries encompass large and diverse populations, with priorities spanning domestic manufacturing, diagnostic access, and stronger cancer-care networks. The European Union benefits from cross-border scientific and regulatory collaboration, although national health-system organization continues to influence implementation. G7 systems generally have mature diagnostic capabilities but remain focused on value, workforce efficiency, equitable access, and evidence-based adoption. GCC countries are investing in advanced healthcare capacity while addressing referral coordination and workforce localization. NATO members include health systems with differing civil infrastructure and procurement models; cooperation can support preparedness, training, and continuity of essential diagnostic services.

Country Insights: Capacity, Pathways, and Workforce Remain Decisive

Australia and Canada combine strong clinical standards with geographic access challenges, particularly outside major centers. Brazil and Mexico must navigate regional disparities in imaging, pathology, and publicly funded referral pathways. China and India are expanding diagnostic capacity while managing substantial urban-rural variation and demand for trained personnel. France, Germany, Italy, Spain, and the United Kingdom have established breast-care pathways, but differ in screening organization, reimbursement, procurement, and waiting-time pressures. Japan and South Korea pair advanced imaging capabilities with aging-population considerations and evolving digital-health integration. Russia’s provision is influenced by centralized planning, regional variation, and access to specialized services. In the United States, sophisticated breast-imaging networks coexist with differences in insurance coverage, affordability, and access across communities.

Recommendations for Leaders: Build Reliable, Equitable Diagnostic Pathways

Industry leaders should prioritize evidence-based procedural protocols, operator training, and quality assurance across imaging, sampling, specimen handling, and pathology correlation. Investments should focus on interoperability, secure clinical data exchange, and AI tools that are prospectively validated and designed for clinician oversight. Partnerships with hospitals, professional societies, payers, and public-health agencies can address referral delays and underserved populations. Organizations should also monitor repeat-biopsy rates, inadequate-sample rates, complications, diagnostic turnaround time, patient experience, and equity by geography and demographic group. Procurement decisions should assess lifecycle support, usability, maintenance, and training rather than equipment functionality alone.

Research Methodology: Evidence-Based Synthesis of Clinical and System Factors

This executive summary synthesizes established clinical principles and publicly documented health-system considerations relevant to ultrasound-guided breast biopsy. The assessment considers procedural use, imaging and pathology coordination, workforce requirements, digital and AI integration, access conditions, and regional variation. Insights are framed qualitatively and avoid market estimation. Interpretation should be complemented by current clinical guidelines, regulatory requirements, peer-reviewed evidence, institutional protocols, and locally verified information before decisions are made.

Conclusion: Pair Technical Capability With Quality, Access, and Oversight

Ultrasound-guided breast biopsy is most effective when embedded in a coordinated diagnostic pathway linking appropriate imaging, skilled sampling, reliable pathology, and timely communication with patients. Regional and country-level differences mean that successful implementation requires more than acquiring equipment: it depends on workforce capability, quality systems, equitable referral, and sustainable follow-up. AI can strengthen this pathway when validated and governed responsibly, while clinical accountability remains central.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Ultrasound-Guided Breast Biopsy Market, by Procedure Type
7.1. Introduction
7.2. Core Needle
7.2.1. 14G
7.2.2. 16G
7.2.3. 18G
7.3. Fine Needle Aspiration
7.4. Vacuum-Assisted Needle
8. Ultrasound-Guided Breast Biopsy Market, by Product
8.1. Introduction
8.2. Accessories
8.3. Needles
8.3.1. Disposable
8.3.2. Reusable
8.4. Systems
8.4.1. Handheld
8.4.2. Tabletop
9. Ultrasound-Guided Breast Biopsy Market, by Lesion Type
9.1. Introduction
9.2. Benign
9.3. Malignant
10. Ultrasound-Guided Breast Biopsy Market, by Imaging Technology
10.1. Introduction
10.2. 3D And 4D
10.3. Real-Time 2D
11. Ultrasound-Guided Breast Biopsy Market, by End Use
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Diagnostic Centers
11.4. Hospitals
12. Ultrasound-Guided Breast Biopsy Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Ultrasound-Guided Breast Biopsy Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Ultrasound-Guided Breast Biopsy Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. ARGON MEDICAL DEVICES, Inc.
16.2. B. Braun Melsungen AG
16.3. Becton, Dickinson and Company
16.4. Canon Medical Systems Corporation
16.5. Cardinal Health, Inc.
16.6. Cook Medical, Inc.
16.7. Danaher Corporation
16.8. Esaote S.p.A.
16.9. Exact Sciences Corp.
16.10. F. Hoffmann-La Roche Ltd
16.11. FUJIFILM Holdings Corporation
16.12. GE HealthCare Technologies Inc.
16.13. Hologic, Inc.
16.14. Izi Medical Products, LLC
16.15. Konica Minolta Healthcare Americas, Inc.
16.16. Koninklijke Philips N.V.
16.17. Medtronic plc
16.18. Merit Medical Systems, Inc.
16.19. Mindray Medical International Limited
16.20. Olympus Corporation
16.21. QIAGEN N.V.
16.22. Samsung Electronics Co., Ltd.
16.23. Siemens Healthineers AG
16.24. Sterylab S.R.L.
16.25. Stryker Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Ultrasound-Guided Breast Biopsy Market, Years Considered for the Study
FIGURE 2. Global Ultrasound-Guided Breast Biopsy Market, Research Design
FIGURE 3. Global Ultrasound-Guided Breast Biopsy Market, Research Framework
FIGURE 4. Global Ultrasound-Guided Breast Biopsy Market, Data Triangulation
FIGURE 5. Global Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2025 vs 2032 (%)
FIGURE 7. Global Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Ultrasound-Guided Breast Biopsy Market Size, by Product, 2025 vs 2032 (%)
FIGURE 9. Global Ultrasound-Guided Breast Biopsy Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2025 vs 2032 (%)
FIGURE 11. Global Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2025 vs 2032 (%)
FIGURE 13. Global Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2025 vs 2032 (%)
FIGURE 15. Global Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Ultrasound-Guided Breast Biopsy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Ultrasound-Guided Breast Biopsy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Ultrasound-Guided Breast Biopsy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Ultrasound-Guided Breast Biopsy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Ultrasound-Guided Breast Biopsy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Ultrasound-Guided Breast Biopsy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Ultrasound-Guided Breast Biopsy Market Segmentation & Coverage
TABLE 2. Global Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 4. Global Core Needle Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Core Needle Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Core Needle Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global 14G Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global 14G Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global 14G Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global 16G Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global 16G Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global 16G Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global 18G Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global 18G Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global 18G Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Fine Needle Aspiration Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Fine Needle Aspiration Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Fine Needle Aspiration Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Vacuum-Assisted Needle Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Vacuum-Assisted Needle Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Vacuum-Assisted Needle Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 23. Global Accessories Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Accessories Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Accessories Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Needles Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Needles Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Needles Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Disposable Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Disposable Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Disposable Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Reusable Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Reusable Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Reusable Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Handheld Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Handheld Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Handheld Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Tabletop Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Tabletop Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Tabletop Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 45. Global Benign Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Benign Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Benign Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Malignant Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Malignant Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Malignant Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 52. Global 3D And 4D Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global 3D And 4D Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global 3D And 4D Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Real-Time 2D Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Real-Time 2D Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Real-Time 2D Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 59. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Ultrasound-Guided Breast Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 78. North America Ultrasound-Guided Breast Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. North America Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 80. North America Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 81. North America Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 82. North America Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 83. North America Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 84. North America Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 85. North America Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 86. North America Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 87. Latin America Ultrasound-Guided Breast Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Latin America Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 89. Latin America Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 90. Latin America Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 91. Latin America Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 92. Latin America Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 93. Latin America Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 94. Latin America Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 95. Latin America Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 96. Europe Ultrasound-Guided Breast Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Europe Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 98. Europe Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 99. Europe Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 100. Europe Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 101. Europe Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 102. Europe Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 103. Europe Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 104. Europe Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 105. Middle East Ultrasound-Guided Breast Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Middle East Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 107. Middle East Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 108. Middle East Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 109. Middle East Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 110. Middle East Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 111. Middle East Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 112. Middle East Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 113. Middle East Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 114. Africa Ultrasound-Guided Breast Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Africa Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 116. Africa Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 117. Africa Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 118. Africa Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 119. Africa Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 120. Africa Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 121. Africa Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 122. Africa Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 123. Global Ultrasound-Guided Breast Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 126. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 127. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 129. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 130. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 131. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 132. ASEAN Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 133. GCC Ultrasound-Guided Breast Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. GCC Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 135. GCC Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 136. GCC Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 137. GCC Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 138. GCC Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 139. GCC Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 140. GCC Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 141. GCC Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 142. European Union Ultrasound-Guided Breast Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. European Union Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 144. European Union Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 145. European Union Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 146. European Union Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 147. European Union Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 148. European Union Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 149. European Union Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 150. European Union Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 151. BRICS Ultrasound-Guided Breast Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. BRICS Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 153. BRICS Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 154. BRICS Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 155. BRICS Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 156. BRICS Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 157. BRICS Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 158. BRICS Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 159. BRICS Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 160. G7 Ultrasound-Guided Breast Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. G7 Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 162. G7 Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 163. G7 Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 164. G7 Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 165. G7 Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 166. G7 Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 167. G7 Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 168. G7 Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 169. NATO Ultrasound-Guided Breast Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. NATO Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 171. NATO Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 172. NATO Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 173. NATO Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 174. NATO Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 175. NATO Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 176. NATO Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 177. NATO Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 178. Global Ultrasound-Guided Breast Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. United States Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 180. United States Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 181. United States Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 182. United States Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 183. United States Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 184. United States Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 185. United States Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 186. United States Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 187. United States Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 188. Canada Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 189. Canada Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 190. Canada Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 191. Canada Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 192. Canada Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 193. Canada Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 194. Canada Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 195. Canada Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 196. Canada Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 197. Mexico Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 198. Mexico Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 199. Mexico Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 200. Mexico Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 201. Mexico Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 202. Mexico Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 203. Mexico Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 204. Mexico Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 205. Mexico Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 206. Brazil Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 207. Brazil Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 208. Brazil Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 209. Brazil Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 210. Brazil Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 211. Brazil Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 212. Brazil Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 213. Brazil Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 214. Brazil Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 215. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 216. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 217. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 218. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 219. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 220. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 221. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 222. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 223. United Kingdom Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 224. Germany Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 225. Germany Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 226. Germany Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 227. Germany Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 228. Germany Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 229. Germany Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 230. Germany Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 231. Germany Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 232. Germany Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 233. France Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 234. France Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 235. France Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 236. France Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 237. France Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 238. France Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 239. France Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 240. France Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 241. France Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 242. Russia Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 243. Russia Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 244. Russia Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 245. Russia Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 246. Russia Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 247. Russia Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 248. Russia Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 249. Russia Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 250. Russia Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 251. Italy Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 252. Italy Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 253. Italy Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 254. Italy Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 255. Italy Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 256. Italy Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 257. Italy Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 258. Italy Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 259. Italy Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 260. Spain Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 261. Spain Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 262. Spain Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 263. Spain Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 264. Spain Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 265. Spain Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 266. Spain Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 267. Spain Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 268. Spain Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 269. China Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 270. China Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 271. China Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 272. China Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 273. China Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 274. China Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 275. China Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 276. China Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 277. China Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 278. India Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 279. India Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 280. India Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 281. India Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 282. India Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 283. India Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 284. India Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 285. India Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 286. India Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 287. Japan Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 288. Japan Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 289. Japan Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 290. Japan Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 291. Japan Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 292. Japan Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 293. Japan Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 294. Japan Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 295. Japan Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 296. Australia Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 297. Australia Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 298. Australia Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 299. Australia Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 300. Australia Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 301. Australia Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 302. Australia Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 303. Australia Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 304. Australia Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 305. South Korea Ultrasound-Guided Breast Biopsy Market Size, 2017-2032 (USD Million)
TABLE 306. South Korea Ultrasound-Guided Breast Biopsy Market Size, by Procedure Type, 2017-2032 (USD Million)
TABLE 307. South Korea Ultrasound-Guided Breast Biopsy Market Size, by Core Needle, 2017-2032 (USD Million)
TABLE 308. South Korea Ultrasound-Guided Breast Biopsy Market Size, by Product, 2017-2032 (USD Million)
TABLE 309. South Korea Ultrasound-Guided Breast Biopsy Market Size, by Needles, 2017-2032 (USD Million)
TABLE 310. South Korea Ultrasound-Guided Breast Biopsy Market Size, by Systems, 2017-2032 (USD Million)
TABLE 311. South Korea Ultrasound-Guided Breast Biopsy Market Size, by Lesion Type, 2017-2032 (USD Million)
TABLE 312. South Korea Ultrasound-Guided Breast Biopsy Market Size, by Imaging Technology, 2017-2032 (USD Million)
TABLE 313. South Korea Ultrasound-Guided Breast Biopsy Market Size, by End Use, 2017-2032 (USD Million)
TABLE 314. Global Ultrasound-Guided Breast Biopsy Market Share, by Key Player, 2025
TABLE 315. Global Ultrasound-Guided Breast Biopsy Market, Key Experts

Companies Mentioned

  • ARGON MEDICAL DEVICES, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Canon Medical Systems Corporation
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • Danaher Corporation
  • Esaote S.p.A.
  • Exact Sciences Corp.
  • F. Hoffmann-La Roche Ltd
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Izi Medical Products, LLC
  • Konica Minolta Healthcare Americas, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Mindray Medical International Limited
  • Olympus Corporation
  • QIAGEN N.V.
  • Samsung Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sterylab S.R.L.
  • Stryker Corporation

Related Topics

Related Reports

Breast Biopsy Market - Global Forecast 2026-2032 - Product Image

Breast Biopsy Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Breast Cancer Core Needle Biopsy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025-2030) - Product Image

Breast Cancer Core Needle Biopsy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025-2030)

  • Report
  • 111 Pages
  • Global
From
Breast Biopsy Market Report 2026 - Product Image

Breast Biopsy Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2026-2034 - Product Image

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2026-2034

  • Report
  • 140 Pages
  • Global
From
Breast Biopsy Devices Market Size, Share & Trends Analysis Report by Product, Procedure, Guidance Technology, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Breast Biopsy Devices Market Size, Share & Trends Analysis Report by Product, Procedure, Guidance Technology, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.